Neonatal Abstinence Syndrome: An emerging issue for Part C systems?

Slides:



Advertisements
Similar presentations
One Science = Early Childhood Pathway for Healthy Child Development Sentinel Outcomes ALL CHILDREN ARE BORN HEALTHY measured by: rate of infant mortality.
Advertisements

Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
Neonatal Abstinence Syndrome: A Family Centered Approach to Care Kelly Outlaw, M.S., CCLS.
Fact sheet Policies and Programs to Address Drug-Exposed Newborns The use or abuse of either illegal or prescription drugs during pregnancy can have serious.
Moms on Meds Substance Abuse During Pregnancy: Jennifer Anderson Maddron, M.D.
Drugs and the Fetus Ashley McArdle Tahnee Seibert Holly Horkman.
KNOWLEDGE: bimonthly webinars, twice-annual statewide meetings to review current best knowledge in NAS treatment AWARENESS: extensive collaboration with.
Childhood Development Affected by Prenatal Drug Abuse Milene Francis Psychology 1100 April, 2014.
Overview of Substance Exposed Newborns Data and Trend Overview.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Chapter Objectives Define maternal, infant, and child health.
Problems in Birth Registration What is the National Standard? Why is the data so important? Joanne M. Wesley Office of the State Registrar.
Chemical Dependency Screening and Referral. By the End of this Session You will be able to: Define substance abuse & related terms Define “disease” as.
Infant Safe Sleep Resources North Carolina Carolinas Medical Center Charlotte, NC September 5, 2007 Christine O’Meara, MA, MPH.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation.
Instructor: Jose Davila
INFANT BIRTH OUTCOMES AMONG SUBSTANCE USING WOMEN: WHY QUITTING SMOKING IS JUST AS IMPORTANT AS QUITTING HARDER DRUGS Beth Bailey, PhD; Judy McCook, PhD,
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
 John McCarthy, M.D.  Executive/Medical Director, Bi-Valley Medical Clinic, Sacramento.
Substance Abuse Pregnancy. Baby Jonah Jonah’s mother was a heroin addict. Shortly after birth, it was obvious Jonah was in withdrawal. His jittery movements.
A Clinical Outcome Study of Meth Exposed Infants Rizwan Z, Shah, M.D., FAAP Blank Children’s Hospital Des Moines, Iowa, USA.
Treatment of Opioid Dependency in Pregnancy and Strategies to Reduce Neonatal Abstinence Syndrome.
Introduction to the Child health Nursing and Nutritional Need Lecture 1 1.
RISE Recovery & Integration Service Substance Use & Pregnancy Liz Thompson Families and Communities Manager.
Drugs and Toxicology Chapter 9. Drugs A substance (either natural or synthetic) that is used to produce effects (either physiological or psychological)
Abusing Drugs During Pregnancy is Child Abuse Hannah Magyar CP English 12 Mrs. Mahoney May 5, 2015.
Neonatal Abstinence Syndrome
Delmar Learning Copyright © 2003 Delmar Learning, a Thomson Learning company Chapter 31 Substance Abuse.
UNDERSTANDING PRENATAL ALCOHOL EXPOSURE
Specific issues in drug use and pregnancy. Pregnant women who use drugs (RCOG, 2010) One of the challenges for pregnant women who use drugs is that they.
Renaissance Prenatal Care Program TM. “Every Renaissance comes to the world with a cry, the cry of the human spirit to be free” -Anne Sullivan Macy.
CityMatCH PPOR Learning Network, Integrating PPOR and FIMR, June 2007 Integrating PPOR and FIMR CityMatCH PPOR Level 2 Learning Network Seminar Call, June.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Care of the Neonate with Prenatal Opioid Exposure – Advanced Practice
Substance Exposed Newborns: Addressing Substance Use Disorder
Introduction to the Child health Nursing and Nutritional Need
Understanding Prenatal Drug Exposure
screening, brief intervention, and referral to treatment
screening, brief intervention and referral to treatment
Pregnancy Dangers.
Chapter 26 Illegal Drugs.
Illinois’ 1115 Behavioral Health Transformation Waiver
Mary Beth Sutter, MD Hannah Watson, MD Sherry Weitzen, MD PhD
Substance Abuse During Pregnancy: The Littlest Victims
Perinatal Advocacy Network (PAN) Videoconference
Neonatal Abstinence Syndrome (NAS) Program Overview
Avoiding Dangers to the Baby
Screening and Referral
Prenatal Development and Birth
Alcohol, Other Drugs, and Health: Current Evidence
Understanding Prenatal Alcohol Exposure
Case Presentations.
Improving Care for Opioid-Exposed Newborns
Adolescent Chemical Dependency
Delaware Dialogue: Addressing Substance Abuse DHMIC Summit 2017
The opioid exposed infant 0-36 months
Medication Assisted Treatment and Pregnancy
The Anthem Difference BHQIP – Case Management has established key contacts within the BHQIP providers to insure timely and efficient communication with.
Gestational Diabetes Lab 4.
Substance-Related and Addictive Disorders
BoRN ADDICTED: Neonatal Abstinence syndrome
Predictors of Breastfeeding: Data from Northeast Tennessee
30-40% of pregnant women receive opioid
The Comprehensive Addiction & Recovery Act 2016 (CARA)
ADDICTION
Treating and Managing Opioid Use Disorder in Pregnancy
The Comprehensive Addiction & Recovery Act 2016 (CARA)
Presentation transcript:

Neonatal Abstinence Syndrome: An emerging issue for Part C systems?

NAS DEFINITION A drug withdrawal syndrome that presents in newborns after birth when transfer of harmful substances from the mother to the fetus abruptly stops at the time of delivery Most frequently due to opioid use in the mother, but may also be seen in infants exposed to benzodiazepines, and alcohol.

NAS Origin Fetal exposure usually occurs for one of three reasons: 1. Mothers are dependent/addicted to opioids, either prescribed or illicit. 2. Mothers require prescription opioids for another disease process 3. Mothers receive methadone therapy to facilitate safe withdrawal from addiction to prescription or illicit opioids.

Opioid Prescriptions Opioid pain relievers and benzodiazepine sedatives are commonly prescribed in the United States. Overprescribing of opioid pain relievers can result in multiple adverse health outcomes. Wide variation exists from one state to another Need for state monitoring of prescribing patterns

Prescribing Rates per 100 Persons

Prevalence of Maternal Opioid Use

Prevalence of NAS

MEAN HOSPITAL CHARGES NATIONAL COST OF HEALTH CARE FOR INFANTS DIAGNOSED WITH NAS: 2000: $190 MILLION 2009: $720 MILLION During that time frame, hospital stay for newborns shortened but average hospital stay for babies with nas stayed the same.

Medical Issues in the Newborn Fetal Growth Low birth weight Growth restriction Breastfeeding Alcohol and Tobacco - Benefits may be outweighed by impact of substances Street Drugs – transmitted through breast milk Methadone use http://pediatrics.aappublications.org/content/early/2013/02/20/peds.2012-3931

Nicotine Alcohol Marijuana Opiates Cocaine Meth Short Term - Birth Fetal Growth Effect Strong Effect No Effect Anomalies No Consensus Withdrawal No Data Neurobehavior Long Term Effects Growth Behavior Cognition Language Achievement

So what does this mean for infant toddler early intervention C? New Population Eligibility Criteria Mother/Baby Dyad Family Dynamics Types of Services Medical Home Involvement Provider Training System Capacity

2015 Tipping Points Question Thirteen States addressing NAS issue: Included in eligibility criteria; At Risk Established Condition; Monitor trends and convened a NAS workgroup to discuss system implications; Clarifying guidance for providers on substance exposed infants and what to consider in the eligibility process.